Valensa in a COVID-19 World

Dear Colleague: Please watch the brief video titled Valensa in a COVID-19 World in which our company addresses how Valensa assures the continuity of your business through comprehensive safety and quality protocols which have been enhanced to address the COVID-19 pandemic.  The video features and interesting conversation between our CEO and one of our production supervisors that […]

Read More »

Valensa Awarded U.S. Patent for Joint Pain Relief

The patent US10,624,919 covers a combination of hyaluronic acid and astaxanthin to alleviate joint deterioration, inflammation, and pain ORLANDO, Fla. (July 8, 2020) — The United States Patent and Trademark Office recently awarded Patent No. 10,624,919 to Florida-based Valensa International for the “Composition and Method to Alleviate Joint Pain Using Low Molecular Weight Hyaluronic Acid […]

Read More »